Author

Thomas C. Victor

Observed names: Thomas C Victor, Thomas Calldo Victor, Thomas Victor, Victor, Thomas

Observed institutions: Human Sciences Research Council, National Health Laboratory Service, South African Medical Research Council, University of North Carolina at Chapel Hill, Harvard University, Swiss Tropical and Public Health Institute, University of Basel, Stellenbosch University, Tygerberg Hospital, University of Oxford, National Research Foundation, Medical Research Council

OpenAlex ID: A5113665180

Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment

1999 · Annelies van Rie, Robin Warren, et al. · New England Journal of Medicine · 599

PDF

Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis

2013 · Maha R Farhat, B Jesse Shapiro, et al. · Nature Genetics · 430

Patients with Active Tuberculosis often Have Different Strains in the Same Sputum Specimen

2004 · Robin M. Warren, Thomas C. Victor, et al. · American Journal of Respiratory and Critical Care Medicine · 291

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa

2013 · Marisa Klopper, Robin Mark Warren, et al. · Emerging infectious diseases · 244

PDF

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

2010 · Keertan Dheda, Karen Shean, et al. · The Lancet · 244

Drug Resistance inMycobacterium tuberculosis

2006 · Rabia Johnson, Elizabeth M Streicher, et al. · Current Issues in Molecular Biology · 227

PDF

Reinfection and Mixed Infection Cause Changing Mycobacterium tuberculosis Drug-Resistance Patterns

2005 · Annelies van Rie, Thomas C. Victor, et al. · American Journal of Respiratory and Critical Care Medicine · 183

Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux

2011 · Gail E. Louw, Robin M. Warren, et al. · American Journal of Respiratory and Critical Care Medicine · 166

Mannose-Binding Protein B Allele Confers Protection against Tuberculous Meningitis

1999 · Eileen G Hoal-Van Helden, Judith Epstein, et al. · Pediatric Research · 166

Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community

2001 · Annelies Van Rie, Robin Warren, et al. · Journal of Clinical Microbiology · 164

Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis

2014 · Philippa A. Black, Robin M. Warren, et al. · Antimicrobial Agents and Chemotherapy · 145

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa

2010 · Alistair D. Calver, Alecia A. Falmer, et al. · Emerging infectious diseases · 141

PDF

The role of IS6110 in the evolution of Mycobacterium tuberculosis

2007 · Christopher R.E. McEvoy, Alecia A. Falmer, et al. · Tuberculosis · 130

Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis

2002 · Miguel Viveiros, Isabel Portugal, et al. · Antimicrobial Agents and Chemotherapy · 110

Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations

2013 · Timothy C. Rodwell, Faramarz Valafar, et al. · Journal of Clinical Microbiology · 102

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates

2015 · Jessica N Torres, Lynthia V Paul, et al. · Emerging Microbes & Infections · 99

The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa

2010 · Thomas R Ioerger, Yicheng Feng, et al. · BMC Genomics · 85

PDF

Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa

2011 · Elizabeth M. Streicher, Borna Müller, et al. · Infection Genetics and Evolution · 75

Pyrosequencing for Rapid Detection of Extensively Drug-Resistant Mycobacterium tuberculosis in Clinical Isolates and Clinical Specimens

2013 · S.-Y. Grace Lin, Timothy C. Rodwell, et al. · Journal of Clinical Microbiology · 73

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks

2013 · Frederick A. Sirgel, Robin M. Warren, et al. · PLoS ONE · 73

PDF

Epidemic Spread of Multidrug-Resistant Tuberculosis in Johannesburg, South Africa

2013 · Ben J. Marais, Charmaine K. Mlambo, et al. · Journal of Clinical Microbiology · 72

PDF

Safe Mycobacterium tuberculosis DNA Extraction Method That Does Not Compromise Integrity

2006 · Robin Warren, Marianna de Kock, et al. · Journal of Clinical Microbiology · 69

Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis

2011 · Frederick A. Sirgel, Marisa Tait, et al. · Microbial Drug Resistance · 68

PDF

Tuberculosis assays: past, present and future

2011 · Novel N Chegou, Kim GP Hoek, et al. · Expert Review of Anti-infective Therapy · 65

Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort Study

2013 · Emily A. Kendall, Danie Theron, et al. · PLoS ONE · 62

PDF

Works count: 75

Citation count: 5,174

H-index: 39

I10-index: 57